Jane Huang Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Jane Huang is CMO, Hematology of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Jun 07, 2021, when has been sold 603 shares (American Depositary Shares) at a price of $351.55 per share, resulting in proceeds of $211,985. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jane Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2021
SELL
Open market or private sale
$211,985 $351.55 p/Share
603 Reduced 100.0%
0 American Depositary Sh...
Jun 01 2021
SELL
Open market or private sale
$195,826 $362.64 p/Share
540 Reduced 100.0%
0 American Depositary Sh...
May 31 2021
BUY
Grant, award, or other acquisition
-
7,189 Added 2.4%
292,772 Ordinary Shares
May 31 2021
BUY
Grant, award, or other acquisition
-
540 Added 50.0%
540 American Depositary Sh...
May 28 2021
SELL
Open market or private sale
$534,825 $356.55 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
May 28 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Apr 29 2021
SELL
Open market or private sale
$531,720 $354.48 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Apr 29 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Mar 29 2021
SELL
Open market or private sale
$486,375 $324.25 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Mar 29 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Feb 26 2021
SELL
Open market or private sale
$478,905 $319.27 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Feb 26 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Jan 29 2021
SELL
Open market or private sale
$486,255 $324.17 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Jan 29 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Dec 29 2020
SELL
Open market or private sale
$373,305 $248.87 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Dec 29 2020
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Nov 30 2020
SELL
Open market or private sale
$403,410 $268.94 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Nov 30 2020
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Oct 29 2020
SELL
Open market or private sale
$451,050 $300.7 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Oct 29 2020
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Sep 29 2020
SELL
Open market or private sale
$420,240 $280.16 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Sep 29 2020
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...

Also insider at

PRLD
Prelude Therapeutics Inc Healthcare
President, CMO
TARA
Protara Therapeutics, Inc. Healthcare
JH

Jane Huang

CMO, Hematology
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE